295 related articles for article (PubMed ID: 28809397)
1. Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium.
Zhang H; Huang X; Liu K; Tang J; He L; Pu W; Liu Q; Li Y; Tian X; Wang Y; Zhang L; Yu Y; Wang H; Hu R; Wang F; Chen T; Wang QD; Qiao Z; Zhang L; Lui KO; Zhou B
Cell Res; 2017 Sep; 27(9):1157-1177. PubMed ID: 28809397
[TBL] [Abstract][Full Text] [Related]
2. Endocardial fibroelastosis is caused by aberrant endothelial to mesenchymal transition.
Xu X; Friehs I; Zhong Hu T; Melnychenko I; Tampe B; Alnour F; Iascone M; Kalluri R; Zeisberg M; Del Nido PJ; Zeisberg EM
Circ Res; 2015 Feb; 116(5):857-66. PubMed ID: 25587097
[TBL] [Abstract][Full Text] [Related]
3. Dual lineage tracing identifies intermediate mesenchymal stage for endocardial contribution to fibroblasts, coronary mural cells, and adipocytes.
Huang X; Feng T; Jiang Z; Meng J; Kou S; Lu Z; Chen W; Lin CP; Zhou B; Zhang H
J Biol Chem; 2019 May; 294(22):8894-8906. PubMed ID: 31010826
[TBL] [Abstract][Full Text] [Related]
4. Mechanical strain triggers endothelial-to-mesenchymal transition of the endocardium in the immature heart.
Vorisek C; Weixler V; Dominguez M; Axt-Fliedner R; Hammer PE; Lin RZ; Melero-Martin JM; Del Nido PJ; Friehs I
Pediatr Res; 2022 Sep; 92(3):721-728. PubMed ID: 34837068
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Fstl1 (Follistatin-Like 1) From the Endocardial/Endothelial Lineage Causes Mitral Valve Disease.
Prakash S; Borreguero LJJ; Sylva M; Flores Ruiz L; Rezai F; Gunst QD; de la Pompa JL; Ruijter JM; van den Hoff MJB
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):e116-e130. PubMed ID: 28705792
[TBL] [Abstract][Full Text] [Related]
6. An animal model of endocardial fibroelastosis.
Friehs I; Illigens B; Melnychenko I; Zhong-Hu T; Zeisberg E; Del Nido PJ
J Surg Res; 2013 Jun; 182(1):94-100. PubMed ID: 22938709
[TBL] [Abstract][Full Text] [Related]
7. A mouse model of endocardial fibroelastosis.
Clark ES; Pepper VK; Best CA; Onwuka EA; Yi T; Tara S; Cianciolo R; Baker P; Shinoka T; Breuer CK
Cardiovasc Pathol; 2015; 24(6):388-94. PubMed ID: 26363814
[TBL] [Abstract][Full Text] [Related]
8. Flow disturbances and progression of endocardial fibroelastosis - a case report.
Weixler V; Hammer PE; Marx GR; Emani SM; Del Nido PJ; Friehs I
Cardiovasc Pathol; 2019; 42():1-3. PubMed ID: 31150840
[TBL] [Abstract][Full Text] [Related]
9. Endocardial Fibroelastosis Resection: When it Works and When it Does Not.
Gierlinger G; Emani SM
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2024; 27():19-24. PubMed ID: 38522867
[TBL] [Abstract][Full Text] [Related]
10. Flow disturbances and the development of endocardial fibroelastosis.
Weixler V; Marx GR; Hammer PE; Emani SM; Del Nido PJ; Friehs I
J Thorac Cardiovasc Surg; 2020 Feb; 159(2):637-646. PubMed ID: 31668539
[TBL] [Abstract][Full Text] [Related]
11. Primary endocardial fibroelastosis: an underappreciated cause of cardiomyopathy in children.
Seki A; Patel S; Ashraf S; Perens G; Fishbein MC
Cardiovasc Pathol; 2013; 22(5):345-50. PubMed ID: 23518027
[TBL] [Abstract][Full Text] [Related]
12. Distention of the Immature Left Ventricle Triggers Development of Endocardial Fibroelastosis: An Animal Model of Endocardial Fibroelastosis Introducing Morphopathological Features of Evolving Fetal Hypoplastic Left Heart Syndrome.
Shimada S; Robles C; Illigens BM; Casar Berazaluce AM; del Nido PJ; Friehs I
Biomed Res Int; 2015; 2015():462469. PubMed ID: 26064914
[TBL] [Abstract][Full Text] [Related]
13. A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition.
Gierlinger G; Rech L; Emani SM; Del Nido PJ; Friehs I
J Vis Exp; 2023 Jul; (197):. PubMed ID: 37677007
[TBL] [Abstract][Full Text] [Related]
14. Endocardial fibroelastosis. Clinico-pathological study of 38 cases.
Angelov A; Kulova A; Gurdevsky M
Pathol Res Pract; 1984 Mar; 178(4):384-8. PubMed ID: 6728720
[TBL] [Abstract][Full Text] [Related]
15. Abnormal Flow Conditions Promote Endocardial Fibroelastosis Via Endothelial-to-Mesenchymal Transition, Which Is Responsive to Losartan Treatment.
Oh NA; Hong X; Doulamis IP; Meibalan E; Peiseler T; Melero-Martin J; García-Cardeña G; Del Nido PJ; Friehs I
JACC Basic Transl Sci; 2021 Dec; 6(12):984-999. PubMed ID: 35024504
[TBL] [Abstract][Full Text] [Related]
16. Histologic and ultrastructural features of primary and secondary endocardial fibroelastosis.
Fishbein MC; Ferrans VJ; Roberts WC
Arch Pathol Lab Med; 1977 Jan; 101(1):49-54. PubMed ID: 576201
[TBL] [Abstract][Full Text] [Related]
17. Sox9 and Rbpj differentially regulate endothelial to mesenchymal transition and wound scarring in murine endovascular progenitors.
Zhao J; Patel J; Kaur S; Sim SL; Wong HY; Styke C; Hogan I; Kahler S; Hamilton H; Wadlow R; Dight J; Hashemi G; Sormani L; Roy E; Yoder MC; Francois M; Khosrotehrani K
Nat Commun; 2021 May; 12(1):2564. PubMed ID: 33963183
[TBL] [Abstract][Full Text] [Related]
18. Endocardial fibroelastosis and dilated cardiomyopathy - the past and future of the interface between histology and genetics.
Luca AC; Lozneanu L; Miron IC; Trandafir LM; Cojocaru E; Pădureţ IA; Mihăilă D; Leon-Constantin MM; Chiriac Ş; Iordache AC; Ţarcă E
Rom J Morphol Embryol; 2020; 61(4):999-1005. PubMed ID: 34171049
[TBL] [Abstract][Full Text] [Related]
19. Endocardial fibroelastosis in infants and young children: a state-of-the-art review.
Aldawsari KA; Alhuzaimi AN; Alotaibi MT; Albert-Brotons DC
Heart Fail Rev; 2023 Sep; 28(5):1023-1031. PubMed ID: 37222928
[TBL] [Abstract][Full Text] [Related]
20. Genetic Fate Mapping Defines the Vascular Potential of Endocardial Cells in the Adult Heart.
Tang J; Zhang H; He L; Huang X; Li Y; Pu W; Yu W; Zhang L; Cai D; Lui KO; Zhou B
Circ Res; 2018 Mar; 122(7):984-993. PubMed ID: 29374073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
